Vice versa, the robust effect of AKT inhibition on SOX2 protein expression that we document here for BC was not consistently observed in other tumor-derived cell types, e.g. in ovarian or squamous head and neck cell carcinoma lines (Supplementary Figure 6). This evidence concerns the gene AKT1 and head and neck squamous cell carcinoma.